Fiduciary Trust Co Has $23.40 Million Stock Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Fiduciary Trust Co lowered its position in Mettler-Toledo International Inc. (NYSE:MTD) by 2.7% in the third quarter, Holdings Channel.com reports. The fund owned 15,600 shares of the medical instruments supplier’s stock after selling 436 shares during the period. Fiduciary Trust Co’s holdings in Mettler-Toledo International were worth $23,395,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. B. Riley Wealth Advisors Inc. bought a new position in Mettler-Toledo International in the 1st quarter valued at $317,000. Plato Investment Management Ltd increased its holdings in shares of Mettler-Toledo International by 1,200.0% in the first quarter. Plato Investment Management Ltd now owns 351 shares of the medical instruments supplier’s stock valued at $467,000 after purchasing an additional 324 shares in the last quarter. Swedbank AB bought a new position in Mettler-Toledo International in the 1st quarter valued at $26,867,000. Atria Investments Inc lifted its stake in shares of Mettler-Toledo International by 0.5% during the first quarter. Atria Investments Inc now owns 2,974 shares of the medical instruments supplier’s stock valued at $3,959,000 after acquiring an additional 15 shares during the period. Finally, Cetera Advisors LLC boosted its holdings in Mettler-Toledo International by 8.0% in the first quarter. Cetera Advisors LLC now owns 459 shares of the medical instruments supplier’s stock valued at $611,000 after acquiring an additional 34 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,243.75 on Thursday. Mettler-Toledo International Inc. has a 1 year low of $1,059.08 and a 1 year high of $1,546.93. The company has a market capitalization of $26.24 billion, a P/E ratio of 33.53, a price-to-earnings-growth ratio of 4.04 and a beta of 1.16. The business has a 50-day moving average of $1,352.26 and a two-hundred day moving average of $1,396.49.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. The firm had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. On average, equities analysts anticipate that Mettler-Toledo International Inc. will post 40.39 EPS for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other news, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares of the company’s stock, valued at $314,820. This trade represents a 24.05 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.94% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Evercore ISI boosted their price objective on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. Stifel Nicolaus dropped their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. JPMorgan Chase & Co. raised their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Wells Fargo & Company cut their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Finally, Robert W. Baird reduced their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $1,338.75.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.